Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home

FKBP5 is a Biomarker for Idiopathic Pulmonary Fibrosis based on a Multi-omic Study Integrating xQTLs

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 01/12/2026 - 09:56
  • Read more about FKBP5 is a Biomarker for Idiopathic Pulmonary Fibrosis based on a Multi-omic Study Integrating xQTLs

Genetic correlations among diaphragmatic, femoral, inguinal, ventral, and umbilical hernias and identification of their candidate genes

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 01/12/2026 - 09:48
  • Read more about Genetic correlations among diaphragmatic, femoral, inguinal, ventral, and umbilical hernias and identification of their candidate genes

Identification of immune cells in benign and malignant thymus tumors: a Mendelian randomization study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 01/12/2026 - 09:46
  • Read more about Identification of immune cells in benign and malignant thymus tumors: a Mendelian randomization study

Bidirectional causal relationships between antibody-mediated immune responses and autoimmune diseases: Insights from Mendelian randomization analysis

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 01/12/2026 - 09:44
  • Read more about Bidirectional causal relationships between antibody-mediated immune responses and autoimmune diseases: Insights from Mendelian randomization analysis

Investigating causal associations between serum metabolites and cataract by Mendelian randomization

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 01/12/2026 - 09:43
  • Read more about Investigating causal associations between serum metabolites and cataract by Mendelian randomization

Whole-genome sequencing reveals contribution of rare and common variation to structural kidney and urinary tract malformations

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 01/07/2026 - 12:52
  • Read more about Whole-genome sequencing reveals contribution of rare and common variation to structural kidney and urinary tract malformations

Application of Mendelian randomization to appraise causality in relationships between the gut microbiome and cancer

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 01/07/2026 - 12:50
  • Read more about Application of Mendelian randomization to appraise causality in relationships between the gut microbiome and cancer

Integrating perturbational screens, eQTL, and GWAS data identifies mediating genes for complex traits

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 01/07/2026 - 12:47
  • Read more about Integrating perturbational screens, eQTL, and GWAS data identifies mediating genes for complex traits

What comes first: Heart rate variability changes or insomnia? A causal investigation using Mendelian randomization

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 01/07/2026 - 10:03
  • Read more about What comes first: Heart rate variability changes or insomnia? A causal investigation using Mendelian randomization

Cell senescence-related pathogenic genes in sleep disorders: a multi-omics Mendelian randomization study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Wed, 01/07/2026 - 10:01
  • Read more about Cell senescence-related pathogenic genes in sleep disorders: a multi-omics Mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 65
  • Page 66
  • Page 67
  • Page 68
  • Current page 69
  • Page 70
  • Page 71
  • Page 72
  • Page 73
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement